Back to results
US 10,517,322 B1Granted
Dietary supplement formulations for promoting sleep
AssigneeLife Kitchen, LLC
InventorJames Wukjae Lee
Life of this patent
Estimating the term…
Abstract
Provided herein are formulations and methods helping individuals enhance cognitive function, facilitate memory processing, induce and maintain sleep, stabilize mood, reduce symptoms of stress and anxiety, facilitate energy production, improve mental and emotional health, or support long-term brain health.
Claims17
A sleep supplement formulation comprising:
- a. L-glutamine or a salt thereof, wherein the L-glutamine is present in an amount from about 1 mg to about 50 mg,
- b. L-theanine or a salt thereof, wherein the L-theanine is present in an amount from about 10 mg to about 300 mg,
- c. taurine or a salt thereof, wherein the taurine is present in an amount from about 10 mg to about 120 mg,
- d. GABA, wherein the GABA is present in an amount from about 10 mg to about 600 mg,
- e. melatonin, wherein the melatonin is present in an amount from about 1 mg to about 20 mg,
- f. phosphatidylserine, wherein the phosphatidylserine is present in an amount from about 0.1 mg to about 4 mg,
- g. myo-inositol, wherein said myo-inositol is present in said formulation in an amount of from about 8 mg to about 40 mg;
- and
- h. one or more physiologically or pharmaceutically acceptable carrier, wherein components (a)-(g) are formulated with the carrier in the form of a solid dosage for promoting sleep.
6 more elements
A method of promoting sleep in an individual in need thereof, by orally administering to the individual a supplement formulation comprising:
- a. L-glutamine or a salt thereof, wherein the L-glutamine is present in an amount from about 8 mg to about 50 mg,
- b. L-theanine or a salt thereof, wherein the L-theanine is present in an amount from about 10 mg to about 300 mg,
- c. taurine or a salt thereof, wherein the taurine is present in an amount from about 10 mg to about 120 mg,
- d. GABA wherein the GABA is present in an amount from about 10 mg to about 600 mg,
- e. melatonin, wherein the melatonin is present in an amount from about 1 mg to about 20 mg,
- f. phosphatidylserine, wherein the phosphatidylserine is present in an amount from about 0.1 mg to about 4 mg,
- g. myo-inositol, wherein said myo-inositol is present in said formulation in an amount of from about 8 mg to about 40 mg;
- and
- one or more physiologically or pharmaceutically acceptable carrier, wherein components (a)-(g) are formulated with the carrier in the form of a solid dosage for promoting sleep.
6 more elements
Dependencies are inferred from the claim text.